Literature DB >> 33565011

Detection of Tumor Multifocality in Resectable Intrahepatic Cholangiocarcinoma: Defining the Optimal Pre-operative Imaging Modality.

Thomas L Sutton1, Kevin G Billingsley1,2, Brett S Walker1, Alice W Fung2,3, Erin Maynard4, C Kristian Enestvedt4, Elizabeth N Dewey5, Brian T Brinkerhoff6, Charles D Lopez2,7, Susan L Orloff4, Skye C Mayo8,9.   

Abstract

BACKGROUND: Multiple tumor foci (MTF) in intrahepatic cholangiocarcinoma (ICC), including satellitosis and true multifocality, is a known negative prognostic factor and can inform pre-operative decision-making. Lack of standardized pre-operative liver staging practices may contribute to undiagnosed MTF and poor outcomes. We sought to investigate the sensitivity of different cross-sectional imaging modalities for MTF at our institution.
METHODS: We identified n = 52 patients with ICC who underwent curative-intent resection from 2004 to 2017 in a multidisciplinary hepato-pancreato-biliary cancer program. Timing and modality of pre-operative imaging were recorded. Blinded review of imaging was performed and modalities were evaluated for false-negative rate (FNR) in detecting MTF, satellitosis, and true multifocality.
RESULTS: Forty-one (79%) patients underwent CT and 20 (38%) underwent MRI prior to hepatectomy. MTF was pre-operatively identified in six (12%) patients. An additional seven patients had MTF discovered on final surgical pathology, despite a median interval from CT/MRI to surgery of 20 days. On blinded review the FNR of MRI compared to CT for multifocality was 0% vs. 38%, 50% vs 80% for satellitosis, and 22% vs 46% for MTF as a whole.
CONCLUSION: CT is inadequate for pre-operative diagnosis of MTF in resectable ICC, even when performed within 30 days of hepatectomy. We recommend liver-protocol MRI as the standard pre-operative imaging modality in non-metastatic ICC.

Entities:  

Keywords:  Detection; Intrahepatic cholangiocarcinoma; Pre-operative imaging; Tumor multifocality

Year:  2021        PMID: 33565011     DOI: 10.1007/s11605-021-04911-8

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  1 in total

Review 1.  Translating cancer genomics for precision oncology in biliary tract cancers.

Authors:  Philipp K Haber; Daniela Sia
Journal:  Discov Med       Date:  2019 Nov-Dec       Impact factor: 2.970

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.